Hence, the therapeutic intervention of the HES1/IGF2BP2/GLUT1 axis-mediated aerobic glycolysis might be a novel strategy for arresting uncontrolled growth and metastasis in CRC. Here, IGF2BP2 is linked to colorectal carcinoma.